Clinical Trials
425 trialsExploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Rare CNS Tumors Outcomes &Risk
National Institutes of Health Clinical Center (CC)
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
REVEAL
Ono Pharmaceutical Co., Ltd.
Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
National Institutes of Health Clinical Center (CC)
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Telix Pharmaceuticals (Innovations) Pty Limited
Development and Implementation of an Intervention Enhancing Involvement of Relatives to Patients With Acquired Brain Injury or Malignant Brain Tumour
Rigshospitalet, Denmark
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
National Institutes of Health Clinical Center (CC)
PROTONBIOMARKS
Centre Leon Berard
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
University of Calgary
Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy
Ohio State University Comprehensive Cancer Center
Patient and Caregiver Priorities in Neuro-oncology Care
Mayo Clinic
NovoTTF Treatment Signatures in Glioblastoma Patients at Autopsy
Medical College of Wisconsin
UFGAG
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
National Institutes of Health Clinical Center (CC)
GM-HES
Chiang Mai University
ERROR
Maastricht Radiation Oncology
C-SMART
Virginia Commonwealth University
Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)
Peking University First Hospital
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
Thomas Jefferson University
Components of Social Functioning in Survivors of Pediatric Brain Tumors
St. Jude Children's Research Hospital
Vestibular Schwannoma Organoids
Maastricht Radiation Oncology
Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma
West China Hospital
Location-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases
West China Hospital
fMRI Reveal Functional Preservation in Glioma Peritumoral Edema
West China Hospital
Precision Medicine for Neurocutaneous Syndromes in Western China
West China Hospital
ML-PNEUMO-BT
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
CAMOMILLE
Fondation Ophtalmologique Adolphe de Rothschild
FET-TREAT
Sunnybrook Health Sciences Centre
Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma
Universitätsklinikum Hamburg-Eppendorf
FDOPA
Centre Hospitalier Universitaire de Nīmes
Evaluating Genetic Modifiers of Cutaneous Neurofibromas in Adults With Neurofibromatosis Type 1
Stanford University
InnovRT1
Assistance Publique - HĂ´pitaux de Paris
Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis
Beijing Tiantan Hospital
Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment
Massachusetts General Hospital
VIGILANT
Arbor Pharmaceuticals, Inc.
HyperArc Registry Study
Varian, a Siemens Healthineers Company
PROGLIO
Centre Jean Perrin
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
Hellenic Cooperative Oncology Group
NEF-1
Assistance Publique - HĂ´pitaux de Paris
BRAIN
Fondation Ophtalmologique Adolphe de Rothschild
A Study of Metabolic Agents Following Brain Radiation
Mayo Clinic
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
Corewell Health West
VERONICA
Huashan Hospital
ONCOhabitats
Universitat Politècnica de València
ALBATROSS
Universitat Politècnica de València
BIOhabitats
Universitat Politècnica de València
PRONOPTIC
Fondation Ophtalmologique Adolphe de Rothschild